Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Scisparc stock (Scisparc)

Learn how to buy Scisparc stock in 5 easy steps.

Scisparc is a biotechnology business based in the US. Scisparc shares (SPRC) are listed on the NASDAQ and all prices are listed in US Dollars. Scisparc employs 3 staff and has a trailing 12-month revenue of around $2.9 million.

Our top picks for where to buy Scisparc stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for Investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy Scisparc stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – SPRC. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Scisparc stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Finder Score: 3.1 / 5: ★★★★★
Stocks, ETFs
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Get up to 15 free stocks
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Scisparc stock price (NASDAQ: SPRC)

Use our graph to track the performance of SPRC stocks over time.

Scisparc shares at a glance

Information last updated 2024-07-21.
Latest market close$0.64
52-week range$0.64 - $15.86
50-day moving average $0.93
200-day moving average $3.23
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-14.43

Is it a good time to buy Scisparc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Scisparc price performance over time

Historical closes compared with the close of $0.643 from 2024-07-19

1 week (2024-07-16) -19.52%
1 month (2024-06-21) -30.55%
3 months (2024-04-23) -47.72%
6 months (2024-01-23) -81.42%
1 year (2023-07-21) 20.41%
2 years (2022-07-21) -98.55%
3 years (2021-07-19) N/A
5 years (2019-07-19) N/A

Scisparc financials

Revenue TTM $2.9 million
Gross profit TTM $1 million
Return on assets TTM -33.12%
Return on equity TTM -73.37%
Profit margin -177.91%
Book value $10.77
Market Capitalization $2.1 million

TTM: trailing 12 months

Scisparc share dividends

We're not expecting Scisparc to pay a dividend over the next 12 months.

Have Scisparc's shares ever split?

Scisparc's shares were split on a 1:26 basis on 27 September 2023. So if you had owned 26 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Scisparc shares – just the quantity. However, indirectly, the new 2500% higher share price could have impacted the market appetite for Scisparc shares which in turn could have impacted Scisparc's share price.

Scisparc share price volatility

Over the last 12 months, Scisparc's shares have ranged in value from as little as $0.638 up to $15.86. A popular way to gauge a stock's volatility is its "beta".

SPRC.US volatility(beta: 1.13)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Scisparc's is 1.129. This would suggest that Scisparc's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

To put Scisparc's beta into context you can compare it against those of similar companies.

Scisparc overview

SciSparc Ltd. , a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd.

Frequently asked questions

What percentage of Scisparc is owned by insiders or institutions?
Currently 0.024% of Scisparc shares are held by insiders and 9.558% by institutions.
How many people work for Scisparc?
Latest data suggests 3 work at Scisparc.
When does the fiscal year end for Scisparc?
Scisparc's fiscal year ends in December.
Where is Scisparc based?
Scisparc's address is: Tower A, Tel Aviv, Israel, 6971916
What is Scisparc's ISIN number?
Scisparc's international securities identification number is: IL0010951403

More guides on Finder

Ask a question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site